Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dawn C Buse

Showing results (81-90 of 230) with videos related to

Pageof 23
Sort By:
Journal of Occupational and Environmental Medicine|April 22, 2011
Longitudinal change in migraine headache-days and indirect cost consequencesWalter F Stewart, G Craig Wood, Christa Bruce, et al.
Journal of Occupational and Environmental Medicine|January 1, 2010
Employment and work impact of chronic migraine and episodic migraineWalter F Stewart, G Craig Wood, Aubrey Manack, et al.
Headache|November 20, 2015
Asthma is a risk factor for new onset chronic migraine: Results from the American migraine prevalence and prevention studyVincent T Martin, Kristina M Fanning, Daniel Serrano, et al.
Headache|November 2, 2022
The unique role of stigma in migraine-related disability and quality of lifeElizabeth K Seng, Robert E Shapiro, Dawn C Buse, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 23, 2013
Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) StudyDaniel Serrano, Aubrey N Manack, Michael L Reed, et al.
Neurology|August 5, 2020
Effect of fremanezumab on quality of life and productivity in patients with chronic migraineRichard B Lipton, Joshua M Cohen, Sanjay K Gandhi, et al.
Headache|September 3, 2013
Impact of NSAID and Triptan use on developing chronic migraine: results from the American Migraine Prevalence and Prevention (AMPP) studyRichard B Lipton, Daniel Serrano, Robert A Nicholson, et al.
Journal of Managed Care & Specialty Pharmacy|July 18, 2020
Burden of Illness Among People with Migraine and ≥ 4 Monthly Headache Days While Using Acute and/or Preventive Prescription Medications for MigraineDawn C Buse, Marianna S Yugrakh, Lulu K Lee, et al.
Clinical Neurology and Neurosurgery|November 17, 2022
Predictors of treatment-response to acute prescription medications in migraine: Results from the American Migraine Prevalence and Prevention (AMPP) StudyAli Ezzati, Dawn C Buse, Kristina M Fanning, et al.
Cephalalgia : an International Journal of Headache|August 18, 2021
What do people want to know about "Growing Up with Migraine"? Results of a preference survey of people with lived experience to guide future researchJames S McGinley, Andrea Savord, Carrie R Houts, et al.
Pageof 23

Showing results (81-90 of 230) with videos related to

Sort By:
Pageof 23
Journal of Occupational and Environmental Medicine|April 22, 2011
Longitudinal change in migraine headache-days and indirect cost consequencesWalter F Stewart, G Craig Wood, Christa Bruce, et al.
Journal of Occupational and Environmental Medicine|January 1, 2010
Employment and work impact of chronic migraine and episodic migraineWalter F Stewart, G Craig Wood, Aubrey Manack, et al.
Headache|November 20, 2015
Asthma is a risk factor for new onset chronic migraine: Results from the American migraine prevalence and prevention studyVincent T Martin, Kristina M Fanning, Daniel Serrano, et al.
Headache|November 2, 2022
The unique role of stigma in migraine-related disability and quality of lifeElizabeth K Seng, Robert E Shapiro, Dawn C Buse, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 23, 2013
Cost and predictors of lost productive time in chronic migraine and episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) StudyDaniel Serrano, Aubrey N Manack, Michael L Reed, et al.
Neurology|August 5, 2020
Effect of fremanezumab on quality of life and productivity in patients with chronic migraineRichard B Lipton, Joshua M Cohen, Sanjay K Gandhi, et al.
Headache|September 3, 2013
Impact of NSAID and Triptan use on developing chronic migraine: results from the American Migraine Prevalence and Prevention (AMPP) studyRichard B Lipton, Daniel Serrano, Robert A Nicholson, et al.
Journal of Managed Care & Specialty Pharmacy|July 18, 2020
Burden of Illness Among People with Migraine and ≥ 4 Monthly Headache Days While Using Acute and/or Preventive Prescription Medications for MigraineDawn C Buse, Marianna S Yugrakh, Lulu K Lee, et al.
Clinical Neurology and Neurosurgery|November 17, 2022
Predictors of treatment-response to acute prescription medications in migraine: Results from the American Migraine Prevalence and Prevention (AMPP) StudyAli Ezzati, Dawn C Buse, Kristina M Fanning, et al.
Cephalalgia : an International Journal of Headache|August 18, 2021
What do people want to know about "Growing Up with Migraine"? Results of a preference survey of people with lived experience to guide future researchJames S McGinley, Andrea Savord, Carrie R Houts, et al.
Pageof 23